Cue Biopharma, Inc.
CUE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645460
In the last 90 days, Cue Biopharma, Inc. insiders filed 0 open-market purchases and 3 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $52.2M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Cue Biopharma, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 100
- +11 vs. Q4 2021
- Shares held
- 17.8M
- +1.28M (+7.7%) vs. Q4 2021
- Total value
- $86.8M
- −$100.4M (−53.6%) vs. Q4 2021
- New holders
- 21
- 28 more added
- Sold out
- 10
- 29 more reduced
2 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CUE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 50 | $52.2M |
| Q1 2026 | 57 | $4.95M |
| Q4 2025 | 49 | $6.67M |
| Q3 2025 | 52 | $13.0M |
| Q2 2025 | 47 | $11.9M |
| Q1 2025 | 49 | $10.4M |
| Q4 2024 | 55 | $12.8M |
| Q3 2024 | 50 | $10.5M |
| Q2 2024 | 75 | $17.1M |
| Q1 2024 | 77 | $31.0M |
| Q4 2023 | 80 | $39.3M |
| Q3 2023 | 75 | $32.1M |
| Q2 2023 | 78 | $50.5M |
| Q1 2023 | 63 | $43.0M |
| Q4 2022 | 61 | $36.4M |
| Q3 2022 | 64 | $28.7M |
| Q2 2022 | 76 | $35.0M |
| Q1 2022 | 100 | $86.8M |
| Q4 2021 | 91 | $187.3M |
| Q3 2021 | 89 | $245.6M |
| Q2 2021 | 90 | $216.4M |
| Q1 2021 | 89 | $229.7M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Cue Biopharma, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Granite Point Capital Management, L.P. | 0 | $0 | 0.00% | −110,000−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −97,062−100.0% | Sold out |
| Precept Management LLC | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −19,819−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −11,813−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −8,675−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −3,030−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −3,020−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −1,132−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| Harbour Investments, Inc. | – | – | – | – | Not filed |
| Reilly Financial Advisors, LLC | – | – | – | – | Not filed |